Gilla Kaplan - 25 Mar 2026 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Reporting relationship: Director
Issuer ticker: TYRA
Reported as of: 25 Mar 2026
Net transaction value: -$528,506
SEC form: 4
Accepted by SEC: 27 Mar 2026, 16:44:50 UTC
Prior SEC filing: 18 Jun 2025
Next SEC filing: 31 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Ali D. Fawaz, Attorney-in-Fact

Key filing fact

Gilla Kaplan filed Form 4 for Tyra Biosciences, Inc. (TYRA) on 27 Mar 2026.

Key facts

This page summarizes Gilla Kaplan's Form 4 filing for Tyra Biosciences, Inc. (TYRA).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 27 Mar 2026, 16:44.

Change

Previous filing in this sequence was filed on 18 Jun 2025.
Current net transaction value: -$528,506.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001247024 Primary reporting owner

KAPLAN GILLA

Relationship: Director
Address: C/O TYRA BIOSCIENCES, INC., 2656 STATE STREET, CARLSBAD
Signature: /s/ Ali D. Fawaz, Attorney-in-Fact
Signature date: 27 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TYRA transaction

Common Stock

Options Exercise

Transaction value
Shares: +14,295
Change %: +51%
Price: $2.25^*
Shares after: 42,526
Date: 25 Mar 2026
Ownership: Direct

TYRA transaction

Common Stock

Sale

Transaction value: $528,506
Shares: -14,295
Change %: -34%
Price: $36.97
Shares after: 28,231
Date: 25 Mar 2026
Ownership: Direct
Footnotes: F1

TYRA transaction

Common Stock

Options Exercise

Transaction value
Shares: -53,172
Change %: -40%
Price: $2.25^*
Shares after: 81,403
Date: 26 Mar 2026
Ownership: Direct

TYRA transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -53,172
Change %: -65%
Price: $37.75^*
Shares after: 28,231
Date: 26 Mar 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TYRA transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -14,295
Change %: -21%
Price: $0.000000^*
Shares after: 53,172
Date: 25 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,295
Exercise price: $2.25
Footnotes: F3

TYRA transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -53,172
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 26 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 53,172
Exercise price: $2.25
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.95 to $37.11. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.25 to $38.125. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F3

Fully vested.